0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 3
  • 1
  • 1
  • 1

PRICE

1
1
1
4

PUBLISHED

0
1
1
4

PRODUCT TYPE

3
1

Search for: "Anhui Anke Biotechnology (Group) Co., Ltd.-Detailed Product Pipeline"

Global Biosimilars Market, 2015 - 2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously,...

Published:  July 2015
Price:  From

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

Published:  July 2016
Price:  From

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

Published:  September 2009
Price:  From

Biologics and Biosimilars World Markets

Biologics are complex molecules manufactured through cell culture recombinant DNA technology Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating...

Published:  August 2013
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group